Cargando…

Retracted: Clinical Efficacy and Safety Analysis of PD-1/PD-L1 Inhibitor vs. Chemotherapy in the Treatment of Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis

Detalles Bibliográficos
Autor principal: International, BioMed Research
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805830/
https://www.ncbi.nlm.nih.gov/pubmed/36597467
http://dx.doi.org/10.1155/2022/9808495
_version_ 1784862414430273536
author International, BioMed Research
author_facet International, BioMed Research
author_sort International, BioMed Research
collection PubMed
description
format Online
Article
Text
id pubmed-9805830
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-98058302023-01-02 Retracted: Clinical Efficacy and Safety Analysis of PD-1/PD-L1 Inhibitor vs. Chemotherapy in the Treatment of Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis International, BioMed Research Biomed Res Int Retraction Hindawi 2022-12-25 /pmc/articles/PMC9805830/ /pubmed/36597467 http://dx.doi.org/10.1155/2022/9808495 Text en Copyright © 2022 BioMed Research International. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
International, BioMed Research
Retracted: Clinical Efficacy and Safety Analysis of PD-1/PD-L1 Inhibitor vs. Chemotherapy in the Treatment of Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis
title Retracted: Clinical Efficacy and Safety Analysis of PD-1/PD-L1 Inhibitor vs. Chemotherapy in the Treatment of Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis
title_full Retracted: Clinical Efficacy and Safety Analysis of PD-1/PD-L1 Inhibitor vs. Chemotherapy in the Treatment of Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis
title_fullStr Retracted: Clinical Efficacy and Safety Analysis of PD-1/PD-L1 Inhibitor vs. Chemotherapy in the Treatment of Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis
title_full_unstemmed Retracted: Clinical Efficacy and Safety Analysis of PD-1/PD-L1 Inhibitor vs. Chemotherapy in the Treatment of Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis
title_short Retracted: Clinical Efficacy and Safety Analysis of PD-1/PD-L1 Inhibitor vs. Chemotherapy in the Treatment of Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis
title_sort retracted: clinical efficacy and safety analysis of pd-1/pd-l1 inhibitor vs. chemotherapy in the treatment of advanced non-small-cell lung cancer: a systematic review and meta-analysis
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805830/
https://www.ncbi.nlm.nih.gov/pubmed/36597467
http://dx.doi.org/10.1155/2022/9808495
work_keys_str_mv AT internationalbiomedresearch retractedclinicalefficacyandsafetyanalysisofpd1pdl1inhibitorvschemotherapyinthetreatmentofadvancednonsmallcelllungcancerasystematicreviewandmetaanalysis